47 related articles for article (PubMed ID: 25436301)
1. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
Yunqiao L; Vanke H; Jun X; Tangmeng G
Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
[TBL] [Abstract][Full Text] [Related]
2. MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1.
Wang Q; Wang GT; Lu WH
Technol Cancer Res Treat; 2021; 20():1533033820957021. PubMed ID: 33827350
[TBL] [Abstract][Full Text] [Related]
3. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir.
Thakral S; Ghoshal K
Curr Gene Ther; 2015; 15(2):142-50. PubMed ID: 25537773
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.
Shibata C; Otsuka M; Kishikawa T; Ohno M; Yoshikawa T; Takata A; Koike K
World J Hepatol; 2015 Jan; 7(1):1-6. PubMed ID: 25624991
[TBL] [Abstract][Full Text] [Related]
5. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.
Yang N; Ekanem NR; Sakyi CA; Ray SD
Adv Drug Deliv Rev; 2015 Jan; 81():62-74. PubMed ID: 25450260
[TBL] [Abstract][Full Text] [Related]
7. Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma.
Wang J; Yao G; Zhang B; Zhao Z; Fan Y
Oncol Lett; 2024 Jan; 27(1):5. PubMed ID: 38028177
[TBL] [Abstract][Full Text] [Related]
8. Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells
He Q; Du H; Li Y
RSC Adv; 2019 Jan; 9(3):1717-1725. PubMed ID: 35518051
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT2 Modulates Pyroptosis of Renal Tubular Cells Induced by High Glucose in Diabetic Nephropathy (DN) by via miR-206 Regulation.
El-Lateef AEA; El-Shemi AGA; Alhammady MS; Yuan R; Zhang Y
Biochem Genet; 2022 Oct; 60(5):1733-1747. PubMed ID: 35084640
[TBL] [Abstract][Full Text] [Related]
10. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
[No Abstract] [Full Text] [Related]
11. MicroRNA-206 has a bright application prospect in the diagnosis of cases with oral cancer.
Wang L; Song H; Yang S
J Cell Mol Med; 2021 Sep; 25(17):8169-8173. PubMed ID: 34418889
[TBL] [Abstract][Full Text] [Related]
12. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.
Yousef MH; El-Fawal HAN; Abdelnaser A
Biomed Res Int; 2020; 2020():9593254. PubMed ID: 33299889
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of angiogenesis-related miRNAs and
de Oliveira ARCP; Castanhole-Nunes MMU; Biselli-Chicote PM; Pavarino ÉC; da Silva RCMA; da Silva RF; Goloni-Bertollo EM
Arch Med Sci; 2020; 16(5):1150-1157. PubMed ID: 32864004
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-206 in osteosarcoma and its associated molecular mechanisms as assessed through TCGA and GEO databases.
Xu X; Qiu B; Yi P; Li H
Oncol Lett; 2020 Mar; 19(3):1751-1758. PubMed ID: 32194668
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic and prognostic value of serum miR-206 in colorectal cancer.
Liu X; Zheng W; Zhang X; Dong M; Sun G
Int J Clin Exp Pathol; 2017; 10(7):7528-7533. PubMed ID: 31966596
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells.
Nasr MA; Salah RA; Abd Elkodous M; Elshenawy SE; El-Badri N
Front Cell Dev Biol; 2019; 7():229. PubMed ID: 31681762
[TBL] [Abstract][Full Text] [Related]
17. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.
Yang Q; Zhang L; Zhong Y; Lai L; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31048362
[TBL] [Abstract][Full Text] [Related]
18. PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.
Gu L; Shi Y; Xu W; Ji Y
Oncol Res; 2019 Aug; 27(8):923-933. PubMed ID: 30982495
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.
Gu J; Liu X; Li J; He Y
Cancer Cell Int; 2019; 19():15. PubMed ID: 30651720
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
